DRISHTI Discoveries
Drishti Discoveries is focused on RNA-targeting genetic therapies for neurodegenerative diseases. They combine RNAi therapeutics and gene therapy using proprietary artificial microRNA technology to develop gene therapies that achieve sustained knockdown of target gene expression.
Industries
genetics
health-care
life-science
therapeutics
Nr. of Employees
small (1-50)
DRISHTI Discoveries
Cambridge, Cambridgeshire, United Kingdom, Europe
Products
Gene therapy platform using artificial microRNA for sustained knockdown
A gene therapy development platform that deploys artificial microRNA constructs to produce long-term suppression of target gene expression for neurodegenerative disease indications.
Gene therapy platform using artificial microRNA for sustained knockdown
A gene therapy development platform that deploys artificial microRNA constructs to produce long-term suppression of target gene expression for neurodegenerative disease indications.
Expertise Areas
- RNAi therapeutic development
- Gene therapy development
- Artificial microRNA design
- Computational target selection / bioinformatics
Key Technologies
- Artificial microRNA-based gene silencing
- RNA interference (RNAi)
- Gene therapy delivery for sustained expression
- Scaffold-specific sequence selection algorithms